Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 14:5:168.
doi: 10.3389/fendo.2014.00168. eCollection 2014.

Aldosterone and the heart: still an unresolved issue?

Affiliations
Review

Aldosterone and the heart: still an unresolved issue?

Cristiana Catena et al. Front Endocrinol (Lausanne). .

Abstract

Receptors for mineralocorticoid hormones are expressed in myocardial cells and evidence obtained in animal studies suggests that activation of these receptors causes cardiac damage independent from blood pressure levels. In the last years, many of the issues related to the effects of aldosterone on the heart have received convincing answers and clinical investigation has focused on a variety of conditions including systolic and diastolic heart failure, arrhythmia, primary hypertension, and primary aldosteronism. Some issues, however, await clarification in order to obtain better understanding of what could be the role of aldosterone blockade in prevention and treatment of cardiovascular diseases. In this article, we overview the most recent findings of animal studies that have examined the contribution of aldosterone to cardiac function and clinical studies that have investigated the influence of aldosterone on left ventricular structure and function in the setting of primary hypertension and primary aldosteronism.

Keywords: adrenalectomy; aldosterone; aldosterone-producing adenoma; bilateral adrenal hyperplasia; echocardiography; left ventricular hypertrophy; left ventricular mass; mineralocorticoid receptor antagonists.

PubMed Disclaimer

References

    1. Lombes M, Alfaidy N, Eugene E, Lessana A, Farman A, Bonvalet JP. Prerequisite for cardiac aldosterone action: mineralocorticoid receptor and 11-β-hydroxysteroid dehydrogenase in the human heart. Circulation (1995) 92:175–8210.1161/01.CIR.92.2.175 - DOI - PubMed
    1. Marney AM, Brown NJ. Aldosterone and end-organ damage. Clin Sci (2007) 113:267–810.1042/CS20070123 - DOI - PubMed
    1. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol (2002) 283:H1802–10 - PubMed
    1. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med (1992) 120:893–901 - PubMed
    1. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, et al. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension (2002) 39:614–8 - PubMed

LinkOut - more resources